Home » Topics » BioWorld Science

BioWorld Science
RSS

Positive phase IIa results reported for Cortecs' oral insulin

Dec. 19, 1997

Oral neuraminidase inhibitor advances to phase II/III

Dec. 19, 1997

CholestaGel enters phase III testing

Dec. 19, 1997

MAb for non-Hodgkin's lymphoma now available in U.S.

Dec. 19, 1997

New warnings added to Posicor labeling

Dec. 19, 1997

Naramig available in Germany

Dec. 19, 1997

RSD-992: a novel 5-HT antagonist with erectogenic activity

Dec. 19, 1997

European approvals for Edronax

Dec. 19, 1997

Patient accrual in Cerestat trials will not resume

Dec. 19, 1997

LeukoSite, Genentech collaborate on IBD therapeutic

Dec. 19, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...